论文部分内容阅读
目的观察TAE方案对难治性急性非淋巴细胞白血病的疗效。方法选择21例难治性急性非淋巴细胞白血病应用TAE方案治疗作为治疗组,选择同期应用其他方案化疗的难治性急性非淋巴细胞白血病24例作为对照组,观察其疗效及不良反应,并进行比较。结果治疗组化疗后完全缓解率及总有效率均明显高于对照组(P<0.05)。结论TAE方案治疗难治性急性非淋巴细胞白血病有明确的疗效,是治疗急性难治性急性非淋巴细胞白血病较好的方案。
Objective To observe the efficacy of TAE regimen in refractory acute non-lymphocytic leukemia. Methods Twenty-one patients with refractory acute non-lymphocytic leukemia treated with TAE regimen were selected as the treatment group. Twenty-four patients with refractory acute non-lymphocytic leukemia who underwent chemotherapy with other regimens during the same period were selected as the control group, and their efficacy and adverse reactions were observed. Compare Results After treatment, the complete remission rate and total effective rate in the treatment group were significantly higher than those in the control group (P <0.05). Conclusion The TAE regimen has a definite curative effect in the treatment of refractory acute non-lymphocytic leukemia and is a good treatment for acute refractory acute non-lymphocytic leukemia.